Martin Siegenthaler
19.09.2017
Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up
Siegenthaler M, Ruschitzka F, Namdar M, Frank M, Olinger E, Debaix H, Widmer U, Pollock E, Krayenbuehl P, Huynh-Do U, Nowak A. Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up. Int J Cardiol 2017; 249:261-267.
19.09.2017Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up
19.09.2017Int J Cardiol 2017; 249:261-267
Siegenthaler Martin, Ruschitzka F, Namdar M, Frank M, Olinger E, Debaix H, Widmer U, Pollock E, Krayenbuehl P, Huynh-Do U, Nowak A
Weiter
28.02.2017
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease
Nowak A, Koch G, Huynh-Do U, Siegenthaler M, Marti H, Pfister M. Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease. Kidney Blood Press Res 2017; 42:1-15.
28.02.2017Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease
28.02.2017Kidney Blood Press Res 2017; 42:1-15
Nowak Albina, Koch Gilbert, Huynh-Do Uyen, Siegenthaler Martin, Marti Hans-Peter, Pfister Marc
Weiter